[alpha]2-adrenoreceptors on human platelets: Selective labelling by [3H]clonidine and [3H]yohimbine and competetive inhibition by antidepressant drugs
Garcia-Sevilla, Jesus A.; Hollingsworth, Peggie J.; Smith, Charles B.
1981-09-24
Citation
Garcia-Sevilla, Jesus A., Hollingsworth, Peggie J., Smith, Charles B. (1981/09/24)."[alpha]2-adrenoreceptors on human platelets: Selective labelling by [3H]clonidine and [3H]yohimbine and competetive inhibition by antidepressant drugs." European Journal of Pharmacology 74(4): 329-341. <http://hdl.handle.net/2027.42/24254>
Abstract
[3H]Clonidine and [3H]yohimbine have been used to characterize [alpha]2-adrenoreceptors on human platelets. At 25[deg]C binding was rapid (t1/2 of association, 1.8 and 2.7 min) and reversible (t1/2 of dissociation, 0.5 and 8.2 min). The binding sites for [3H]clonidine and [3H]yohimbine showed the specificity required for an [alpha]2-adrenoreceptor. The rank order of potency of inhibitors of [3H] clonidine binding was clonidine > yohimbine >> phenylephrine > prazosin and of [3H]yohimbine binding was yohimbine > clonidine >> phenylephrine > prazosin. Scatchard analysis of [3H]yohimbine binding indicated the existence of a single population of noninteracting sites (KD = 3.0 nM; Bmax = 188 fmol/mg protein). The high-affinity binding of [3H]clonidine had a lower affinity and a lower number of sites (KD = 5.0 nM; Bmax = 35 fmol/mg protein). [3H]Clonidine binding also showed evidence of a second site of much lower affinity and greater number (KD = 18.6 nM; Bmax = 77 fmol/mg protein) in 40% of the normal population. In vitro, antidepressant drugs competed with [3H]clonidine and [3H]yohimbine for the platelet [alpha]2-adrenoreceptor. The rank order of potency of inhibitors of [3H]clonidine binding was mianserin > amitriptyline >> iprindole > desipramine and of [3H]yohimbine binding was mianserin > amitriptyline >> desipramine > iprindole. The inhibition constants (Ki) of adrenergic drugs and of various antidepressant drugs in competing with [3H]clonidine were correlated with the inhibition constants of these drugs in competing with [3H]yohimbine (r=0.970; P2-adrenoreceptor on the human platelet. The inhibition of binding induced by all antidepressant drugs was competitive. In contrast, long-term administration of tricyclic antidepressant drugs to patients was recently found to be associated with a decrease in the number of binding sites for [3H]clonidine on platelet membranes. The present results indicate that both [3H]clonidine and [3H]yohimbine are useful tools for the quantification of [alpha]2-adrenoreceptors on blood platelets and suggests that the specific binding of radiolabelled [alpha]2-adrenoreceptor ligands to human platelet membranes might be used to monitor changes in [alpha]2-adrenoreceptors during tricyclic antidepressant drug treatment.Publisher
Elsevier
PMID
6271559
Types
Article
URI
http://www.sciencedirect.com/science/article/B6T1J-479DVBX-T2/2/6a8a00e8587207e9550268cdf43c8aaahttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=6271559&dopt=citation
Metadata
Show full item recordRemediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.